Target intelligence / Profile preview

Kinesin-like protein KIF20A (KIF20A)

Target
KIF20A
Molecular classification
Kinesin family, Motor protein, Enzyme, ATPase
01

Overview

Kinesin-like protein KIF20A, also known as Mitotic kinesin-like protein 2 (MKLP2), is a member of the kinesin-6 family that plays a fundamental role in the final stages of cell division. It is essential for cytokinesis, where it drives the transport of the chromosomal passenger complex to the spindle midbody to facilitate daughter cell separation [1][2]. While its expression is restricted in healthy adult tissues—primarily found in the testis and thymus—it is significantly overexpressed in a variety of malignant tumors, including pancreatic and biliary tract cancers [3][4]. The specific designation 'KIF20A-66' refers to a 9-mer peptide (sequence: KVLRVLSAV) derived from this protein that serves as a highly immunogenic, HLA-A*24:02-restricted epitope [2][5]. In clinical oncology, this peptide is utilized as a therapeutic vaccine designed to stimulate the immune system to produce cytotoxic T lymphocytes that target and destroy KIF20A-positive cancer cells [4][6]. Beyond immunotherapy, KIF20A is also a target for small-molecule inhibitors that aim to arrest the cell cycle by disrupting its ATPase activity and microtubule-binding functions [1][7]. Sources: [1] UniProt (O95235): Kinesin-like protein KIF20A. [2] PubMed (PMID: 21544254): Identification of KIF20A-derived peptide vaccine for pancreatic cancer. [3] PubMed (PMID: 25217671): Phase I/II clinical trial of KIF20A peptide vaccine for biliary tract cancer. [4] ClinicalTrials.gov: Studies involving KIF20A-66 and MKLP2. [5] PubMed (PMID: 24391102): KIF20A as a prognostic biomarker and therapeutic target. [6] PubMed (PMID: 28383433): Immunotherapy targeting kinesin superfamily proteins. [7] PubChem: Information on MKLP2/KIF20A inhibitors like Paprotrain.

Other names
MKLP2Mitotic kinesin-like protein 2Rab6-interacting kinesin-like proteinRAB6KIFLKinesin-6KIF20A-66 (peptide epitope)
02

Mechanism of action

KIF20A-66 is a peptide-based cancer vaccine that induces HLA-A*24:02-restricted cytotoxic T lymphocytes (CTLs) to recognize and lyse tumor cells overexpressing the KIF20A protein.

03

Biological functions

Cell cycleCytokinesisIntracellular transportMitosisMicrotubule-based movementOrganelle localization
04

Disease associations

CancerPancreatic cancerBiliary tract cancerGastric cancerLung cancerHepatocellular carcinomaBreast cancer
05

Safety considerations

Injection site reactionsPotential toxicity to normal dividing cells (testis and thymus)Immune-related adverse eventsTherapeutic resistance through epitope loss
06

Interacting drugs

KIF20A-66 peptide vaccine

3 more in the full profile.

07

Biomarkers

KIF20A expression levelHLA-A*24:02 genotypeCTL response induction

Beyond the preview

Go deeper on Kinesin-like protein KIF20A (KIF20A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Kinesin-like protein KIF20A (KIF20A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call